Cardlytics Stock Today

CDLX Stock  USD 14.49  0.15  1.02%   

Performance

8 of 100

 
Low
 
High
OK

Odds Of Distress

Less than 44

 
100  
 
Zero
Below Average
Cardlytics is trading at 14.49 as of the 29th of March 2024; that is -1.02 percent decrease since the beginning of the trading day. The stock's open price was 14.64. Cardlytics has about a 44 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Cardlytics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of April 2023 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain
Media & Entertainment
IPO Date
9th of February 2018
Category
Communication Services
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. The company has 44.11 M outstanding shares of which 4.48 M shares are currently shorted by private and institutional investors with about 2.9 trading days to cover. More on Cardlytics

Moving together with Cardlytics Stock

  0.66DRCT Direct Digital Holdings Financial Report 9th of May 2024 PairCorr

Moving against Cardlytics Stock

  0.74WMG Warner Music Group Financial Report 14th of May 2024 PairCorr
  0.69EVC Entravision Communications Financial Report 2nd of May 2024 PairCorr
  0.66IAS Integral Ad Science Buyout TrendPairCorr
  0.54ABTS Abits Group Symbol ChangePairCorr
  0.43RSVRW Reservoir Media ManaPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Cardlytics Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cardlytics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cardlytics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, Co-Founder and DirectorScott Grimes
Business ConcentrationAdvertising, Media & Entertainment, Communication Services, NASDAQ Composite, Communication Services, Media, Advertising Agencies, Communication Services (View all Sectors)
Average Analyst Recommendation
Analysts covering Cardlytics report their recommendations after researching Cardlytics' financial statements, talking to executives and customers, or listening in on Cardlytics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Cardlytics. The Cardlytics consensus assessment is calculated by taking the average forecast from all of the analysts covering Cardlytics.
Cardlytics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Cardlytics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardlytics' financial leverage. It provides some insight into what part of Cardlytics' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Cardlytics' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Cardlytics deploys its capital and how much of that capital is borrowed.
Liquidity
Cardlytics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 266.11 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cardlytics until it has trouble settling it off, either with new capital or with free cash flow. So, Cardlytics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardlytics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardlytics to invest in growth at high rates of return. When we think about Cardlytics' use of debt, we should always consider it together with cash and equity.

Depreciation

16.84 Million
Cardlytics (CDLX) is traded on NASDAQ Exchange in USA. It is located in 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 and employs 434 people. Cardlytics is listed under Advertising category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 645.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cardlytics's market, we take the total number of its shares issued and multiply it by Cardlytics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cardlytics conducts business under Media sector and is part of Communication Services industry. The entity has 44.11 M outstanding shares of which 4.48 M shares are currently shorted by private and institutional investors with about 2.9 trading days to cover. Cardlytics currently holds about 157.04 M in cash with (185 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77.
Check Cardlytics Probability Of Bankruptcy
Ownership Allocation
Cardlytics retains a total of 44.11 Million outstanding shares. Over half of Cardlytics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Cardlytics. Please watch out for any change in the institutional holdings of Cardlytics as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Cardlytics Ownership Details

Cardlytics Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Cardlytics jumping above the current price in 90 days from now is roughly 2.44%. The Cardlytics probability density function shows the probability of Cardlytics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 3.1845 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cardlytics will likely underperform. Additionally, cardlytics has an alpha of 0.9903, implying that it can generate a 0.99 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 14.49HorizonTargetOdds Above 14.49
97.55%90 days
 14.49 
2.44%
Based on a normal probability distribution, the odds of Cardlytics to move above the current price in 90 days from now is roughly 2.44 (This Cardlytics probability density function shows the probability of Cardlytics Stock to fall within a particular range of prices over 90 days) .

Cardlytics Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Cardlytics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cardlytics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardlytics' value.
InstituionRecorded OnShares
D. E. Shaw & Co Lp2023-09-30
702.9 K
Marshall Wace Asset Management Ltd2023-12-31
623.4 K
Goldman Sachs Group Inc2023-12-31
593.4 K
Davidson Kempner Capital Management Lp2023-12-31
550 K
Nuveen Asset Management, Llc2023-12-31
520.7 K
General Equity Holdings Lp2023-09-30
476.2 K
Lpl Financial Corp2023-12-31
453.4 K
Landscape Capital Management,llc2023-12-31
350 K
Northern Trust Corp2023-12-31
320.2 K
Blackrock Inc2023-12-31
2.9 M
Vanguard Group Inc2023-12-31
2.2 M
View Cardlytics Diagnostics

Cardlytics Historical Income Statement

Cardlytics Income Statement is one of the three primary financial statements used for reporting Cardlytics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Cardlytics revenue and expense. Cardlytics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Cardlytics' Selling And Marketing Expenses is fairly stable compared to the past year. Income Tax Expense is likely to rise to about 141.4 M in 2024, whereas Interest Income is likely to drop slightly above 3.4 M in 2024. View More Fundamentals

Cardlytics Stock Against Markets

Picking the right benchmark for Cardlytics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cardlytics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cardlytics is critical whether you are bullish or bearish towards Cardlytics at a given time. Please also check how Cardlytics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cardlytics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Cardlytics Corporate Directors

Cardlytics corporate directors refer to members of a Cardlytics board of directors. The board of directors generally takes responsibility for the Cardlytics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cardlytics' board members must vote for the resolution. The Cardlytics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Bryce YoungrenIndependent DirectorProfile
John KlinckIndependent DirectorProfile
Aimee LapicDirectorProfile
Tony WeismanIndependent DirectorProfile

How to buy Cardlytics Stock?

Before investing in Cardlytics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cardlytics. To buy Cardlytics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cardlytics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Cardlytics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Cardlytics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Cardlytics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cardlytics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Already Invested in Cardlytics?

The danger of trading Cardlytics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cardlytics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cardlytics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cardlytics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Cardlytics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardlytics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardlytics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardlytics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Cardlytics Stock analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.57)
Earnings Share
(3.69)
Revenue Per Share
8.474
Quarterly Revenue Growth
0.081
Return On Assets
(0.06)
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.